Our lab focuses on using the high-throughput technologies of the post-genomic era to characterize microbial diversity and function in human-associated microbial communities.

Areas of research under investigation include

(i) the role of the human gut microbiota as contributors to fatty liver,
(ii) the use of next generation sequencing technology to characterize infections in Cystic Fibrosis,
(iii) the role of adherent mucosal bacteria in normal colon of patients with (case) and without (control) adenomas and
(iv) probiotics as mediators of gut inflammation and as chemopreventive agents.

Our lab has a long-standing interest in bioinformatics algorithms and development of new tools for the visualization and interpretation of genomic data.